vs
Progyny, Inc.（PGNY）与Quipt Home Medical Corp.（QIPT）财务数据对比。点击上方公司名可切换其他公司
Progyny, Inc.的季度营收约是Quipt Home Medical Corp.的6.5倍（$318.4M vs $49.0M）。Progyny, Inc.净利率更高（3.9% vs -2.1%，领先6.1%）。Quipt Home Medical Corp.同比增速更快（32.3% vs 6.7%）。Progyny, Inc.自由现金流更多（$48.6M vs $6.9M）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
Quipt Home Medical Corp是一家总部位于美国的家用医疗设备服务商，主营呼吸护理、睡眠治疗用品及慢性病管理相关医疗产品，面向慢性病患者群体提供服务，合作方涵盖医疗机构与保险支付机构。
PGNY vs QIPT — 直观对比
营收规模更大
PGNY
是对方的6.5倍
$49.0M
营收增速更快
QIPT
高出25.6%
6.7%
净利率更高
PGNY
高出6.1%
-2.1%
自由现金流更多
PGNY
多$41.7M
$6.9M
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $49.0M |
| 净利润 | $12.5M | $-1.1M |
| 毛利率 | 24.1% | 53.5% |
| 营业利润率 | 4.8% | 2.1% |
| 净利率 | 3.9% | -2.1% |
| 营收同比 | 6.7% | 32.3% |
| 净利润同比 | 18.5% | 2.9% |
| 每股收益（稀释后） | $0.14 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYQIPT
| Q4 25 | $318.4M | $49.0M | ||
| Q3 25 | $313.3M | $39.8M | ||
| Q2 25 | $332.9M | $35.1M | ||
| Q1 25 | $324.0M | $33.3M | ||
| Q4 24 | $298.4M | $37.1M | ||
| Q3 24 | $286.6M | — | ||
| Q2 24 | $304.1M | — | ||
| Q1 24 | $278.1M | — |
净利润PGNYQIPT
| Q4 25 | $12.5M | $-1.1M | ||
| Q3 25 | $13.9M | $-3.5M | ||
| Q2 25 | $17.1M | $-3.0M | ||
| Q1 25 | $15.1M | $-3.0M | ||
| Q4 24 | $10.5M | $-1.1M | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $16.5M | — | ||
| Q1 24 | $16.9M | — |
毛利率PGNYQIPT
| Q4 25 | 24.1% | 53.5% | ||
| Q3 25 | 23.2% | 48.7% | ||
| Q2 25 | 23.7% | 57.6% | ||
| Q1 25 | 23.4% | 54.6% | ||
| Q4 24 | 21.3% | 52.1% | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 22.4% | — |
营业利润率PGNYQIPT
| Q4 25 | 4.8% | 2.1% | ||
| Q3 25 | 6.9% | -3.6% | ||
| Q2 25 | 7.3% | -5.2% | ||
| Q1 25 | 7.5% | -3.0% | ||
| Q4 24 | 5.3% | 1.2% | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | 6.7% | — |
净利率PGNYQIPT
| Q4 25 | 3.9% | -2.1% | ||
| Q3 25 | 4.4% | -8.9% | ||
| Q2 25 | 5.1% | -8.6% | ||
| Q1 25 | 4.6% | -9.1% | ||
| Q4 24 | 3.5% | -2.9% | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 6.1% | — |
每股收益（稀释后）PGNYQIPT
| Q4 25 | $0.14 | $-0.02 | ||
| Q3 25 | $0.15 | $-0.07 | ||
| Q2 25 | $0.19 | $-0.07 | ||
| Q1 25 | $0.17 | $-0.07 | ||
| Q4 24 | $0.12 | $-0.03 | ||
| Q3 24 | $0.11 | — | ||
| Q2 24 | $0.17 | — | ||
| Q1 24 | $0.17 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | $10.5M |
| 总债务越低越好 | — | $84.0M |
| 股东权益账面价值 | $516.0M | $113.0M |
| 总资产 | $742.4M | $280.7M |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资PGNYQIPT
| Q4 25 | $112.2M | $10.5M | ||
| Q3 25 | $134.0M | $12.9M | ||
| Q2 25 | $132.5M | $11.3M | ||
| Q1 25 | $109.2M | $17.1M | ||
| Q4 24 | $162.3M | $15.5M | ||
| Q3 24 | $91.5M | — | ||
| Q2 24 | $95.0M | — | ||
| Q1 24 | $115.0M | — |
总债务PGNYQIPT
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PGNYQIPT
| Q4 25 | $516.0M | $113.0M | ||
| Q3 25 | $560.0M | $112.1M | ||
| Q2 25 | $515.0M | $102.5M | ||
| Q1 25 | $467.2M | $103.6M | ||
| Q4 24 | $422.1M | $106.3M | ||
| Q3 24 | $434.9M | — | ||
| Q2 24 | $456.2M | — | ||
| Q1 24 | $571.6M | — |
总资产PGNYQIPT
| Q4 25 | $742.4M | $280.7M | ||
| Q3 25 | $795.2M | $283.3M | ||
| Q2 25 | $761.0M | $236.1M | ||
| Q1 25 | $730.3M | $244.6M | ||
| Q4 24 | $607.1M | $242.8M | ||
| Q3 24 | $660.0M | — | ||
| Q2 24 | $698.6M | — | ||
| Q1 24 | $794.3M | — |
负债/权益比PGNYQIPT
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $8.9M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $6.9M |
| 自由现金流率自由现金流/营收 | 15.3% | 14.0% |
| 资本支出强度资本支出/营收 | 1.8% | 4.2% |
| 现金转化率经营现金流/净利润 | 4.34× | — |
| 过去12个月自由现金流最近4个季度 | $191.8M | $26.6M |
8季度趋势，按日历期对齐
经营现金流PGNYQIPT
| Q4 25 | $54.2M | $8.9M | ||
| Q3 25 | $50.7M | $9.8M | ||
| Q2 25 | $55.5M | $9.7M | ||
| Q1 25 | $49.8M | $8.9M | ||
| Q4 24 | $52.2M | $9.3M | ||
| Q3 24 | $44.5M | — | ||
| Q2 24 | $56.7M | — | ||
| Q1 24 | $25.7M | — |
自由现金流PGNYQIPT
| Q4 25 | $48.6M | $6.9M | ||
| Q3 25 | $46.0M | $8.0M | ||
| Q2 25 | $50.2M | $4.4M | ||
| Q1 25 | $47.0M | $7.3M | ||
| Q4 24 | $50.3M | $5.6M | ||
| Q3 24 | $42.7M | — | ||
| Q2 24 | $55.8M | — | ||
| Q1 24 | $24.9M | — |
自由现金流率PGNYQIPT
| Q4 25 | 15.3% | 14.0% | ||
| Q3 25 | 14.7% | 20.0% | ||
| Q2 25 | 15.1% | 12.6% | ||
| Q1 25 | 14.5% | 22.0% | ||
| Q4 24 | 16.8% | 15.2% | ||
| Q3 24 | 14.9% | — | ||
| Q2 24 | 18.4% | — | ||
| Q1 24 | 8.9% | — |
资本支出强度PGNYQIPT
| Q4 25 | 1.8% | 4.2% | ||
| Q3 25 | 1.5% | 4.6% | ||
| Q2 25 | 1.6% | 14.9% | ||
| Q1 25 | 0.9% | 4.8% | ||
| Q4 24 | 0.6% | 9.9% | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
现金转化率PGNYQIPT
| Q4 25 | 4.34× | — | ||
| Q3 25 | 3.65× | — | ||
| Q2 25 | 3.24× | — | ||
| Q1 25 | 3.31× | — | ||
| Q4 24 | 4.95× | — | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 1.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
QIPT
暂无分部数据
